drugset / Trial / NCT06493838

Clinical Efficacy of Prophylactic Intravenous Neostigmine and Atropine in Preventing Post-Dural Puncture Headache Among Parturient Undergoing Spinal Anesthesia for Cesarean Section: A Double-blind Randomized Placebo-controlled Trial

NCT06493838

Phase 4 Not yet recruiting 180 enrolled Minia University
RandomizedParallel-groupDouble-blindPrevention

Summary

Post dural puncture headache is a distressing issue, many measures tried to treat symptoms but few delt with prevention.

Timeline

Start
2024-07-15
Primary completion
2025-01-15
Completion
2025-01-16

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atropine Other / unclassified 0.01 mg/kg Intravenous
Comparator Neostigmine Other / unclassified 20 ug/kg Intravenous

Indications

No indication recorded.